Top compounds associated with response to SPRR2G


Feature Type Standardized
Nominal ANOVA
mRNA CD-437 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.045 0.4
mRNA etoposide CTRPv2 pan-cancer AAC -0.025 0.4
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.031 0.4
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC 0.032 0.4
mRNA AS605240 GDSC1000 pan-cancer AAC -0.03 0.4
mRNA paclitaxel GDSC1000 pan-cancer AAC -0.043 0.4
mRNA manumycin A CTRPv2 pan-cancer AAC -0.026 0.4
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.032 0.4
Download CSV